Heart Valve Technology

This channel includes news and new device innovations about heart valve technologies, including the aortic valve, mitral valve, pulmonic valve, and tricuspid valve. This includes information on transcatheter valve technologies like transcatheter aortic valve replacement (TAVR, or implantation TAVI), transcatheter mitral valve repair or replacement (TMVR), transcatheter and surgical valve repairs, and surgical replacement valves. Newer devices are now being used for transcatheter tricuspid valve repair replacement (TTVR). 

News | Heart Valve Technology

December 10, 2015 — Mitralign Inc. announced the first U.S. subject has been enrolled in the SCOUT Study using the ...

Home December 10, 2015
Home
News | Heart Valve Technology

November 23, 2015 — NaviGate Cardiac Structures Inc. (NCSI) announced that a first-in-human implant of its catheter ...

Home November 23, 2015
Home
Neovasc, Tiara, transcatheter mitral valve, TMVR
Feature | Heart Valve Technology | Dave Fornell

(This article was updated in June 2018)


The advent of transcatheter valve repair and replacement technologies is one ...

Home November 12, 2015
Home
News | Heart Valve Technology

November 10, 2015 — PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania in a randomized ...

Home November 10, 2015
Home
Blog | Cath Lab

For the past few years, the focus of the annual Transcatheter Cardiovascular Therapeutics (TCT) meetings has been on ...

Home November 05, 2015
Home
Videos | TCT

Tom Watson, clinical analyst for MDBuyLine, and DAIC Editor Dave Fornell discuss some of the new cardiovascular and ...

Home November 05, 2015
Home
News | Heart Valve Technology

October 27, 2015 — A large observational registry found that initial aortic valve replacement (AVR) in asymptomatic ...

Home October 27, 2015
Home
News | Heart Valve Technology

October 22, 2015 — Direct Flow Medical Inc. announced one-year outcomes from the DISCOVER post-market study that ...

Home October 22, 2015
Home
BRAVO 3 trial results, bivalirudin, heparin, anticoagulation, TAVR, TCT 2015
Feature | Antiplatelet and Anticoagulation Therapies

October 20, 2015 — Results from the BRAVO 3 trial found that bivalirudin did not significantly reduce major bleeding ...

Home October 20, 2015
Home
Amaranth Fortitute Bioresorbable stent
Feature | TCT | Tom Watson, BS, RCVT, Clinical Analyst, MD Buyline

There were several overarching technology trends seen at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) annual ...

Home October 19, 2015
Home
Claret embolic protection, TAVR, cerebral protection
Feature | Heart Valve Technology

October 14, 2015 — Claret Medical, an innovator in cardiovascular cerebral protection, Data presented this week at ...

Home October 16, 2015
Home
News | Heart Valve Technology

October 15, 2015 — Edwards Lifesciences Corp. announced that details on the 13 first-in-human compassionate use cases wi ...

Home October 15, 2015
Home
PARTNER II Trial, TCT 2015, Edwards Lifesciences, Sapien 3 valve, one-year results
Feature | Heart Valve Technology

October 15, 2015 — One-year patient outcomes from the PARTNER II trial showed the low rate of 30-day complications with ...

Home October 15, 2015
Home
Technology | Heart Valve Technology

October 15, 2015 — U.S. Food and Drug Administration (FDA) has cleared Edwards Lifesciences Sapien XT transcatheter ...

Home October 15, 2015
Home
Subscribe Now